Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Glucagonoma secondary prevention
Introduction
Overview
Overview
Secondary prevention measures of glucagonoma include routine glucagon levels and imaging at scheduled intervals after treatment.
Secondary Prevention
Secondary Prevention
Guidelines from the National Comprehensive Cancer Network include the following recommendations for follow-up after treatment of a pancreatic neuroendocrine tumor:[1]
- Three to 12 months post-resection: History and physical examination, serum glucagon level, and computed tomography or magnetic resonance imaging.
- More than one-year post-resection to a maximum of 10 years: history and physical examination with serum glucagon level every 6 to 12 months. Imaging studies as clinically indicated.
References
References
- National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on February 27, 2016).
- ↑ Halvorson SA, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M; et al. (2013). “Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome”. J Gen Intern Med. 28 (11): 1525–9. doi:10.1007/s11606-013-2490-5. PMC 3797362. PMID 23681843.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]